Top Startup and Tech Funding News – October 13, 2025

It’s Monday, October 13, 2025, and we’re back with the top startup and tech funding news stories making waves today. It’s a quiet day on the funding front with markets closed for the U.S. holiday. We’ll be back in full swing tomorrow when business resumes.

From multibillion-dollar AI ambitions to breakthroughs in precision agriculture, biotech, and insurtech, capital continued to flow across every stage — from early seed rounds to billion-dollar growth financings.

Today’s highlights feature Reflection AI’s $2 billion Series B to advance open-source AI models, Ecorobotix’s $105 million Series D to revolutionize precision farming, and HavocAI’s $85 million raise to scale its autonomous naval fleet systems. In biotech, Excellergy launched with a $70 million Series A to combat severe allergic diseases, while Resistant AI secured $25 million to strengthen fraud detection in financial services. Fintech and insurtech also saw momentum, with GoodScore and ClaimSorted raising fresh capital to expand their AI-driven platforms.

Funding Highlights

• Reflection AI raised $2 billion to build open-source AI infrastructure and models.

• Ecorobotix secured $105 million in Series D funding to expand its precision agriculture robots.

• HavocAI landed $85 million to scale its autonomous naval systems for defense.

• Excellergy launched with $70 million Series A funding for next-gen allergy therapeutics.

• Resistant AI raised $25 million in Series B funding to fight digital and document fraud.

• GoodScore raised $13 million in Series A funding to boost its AI-powered credit health platform.

• ClaimSorted closed $13.3 million in Seed to modernize the insurance claims process.

• Salt AI secured $10 million in Pre-Series A to accelerate AI in life sciences.

Investor Activity
Today’s rounds drew participation from top global investors, including Nvidia, Highland Europe, Samsara BioCapital, B Capital, In-Q-Tel, Atomico, and Peak XV Partners, along with strategic backers such as Google Ventures, Lockheed Martin, and CoreWeave. Their collective bets signal continued confidence in AI infrastructure, sustainability, fintech, and biotech innovation.

Together, these financings highlight the resilience of global venture markets — even as macro conditions remain uncertain — and show that founders building real, scalable technologies continue to attract serious capital.

Here’s the full breakdown. Until tomorrow, have a great evening.

Reflection AI Raises $2 Billion in Series B Funding to Build Open-Source AI Labs

Reflection AI, a Brooklyn-based AI startup aiming to rival closed AI labs like OpenAI, has secured a massive $2 billion in Series B funding at an $8 billion valuation. Founded just last year by former Google DeepMind researchers, the company initially emerged from stealth in March after raising $130 million, and it is now doubling down on developing “frontier” large language models that are fully open source.

The latest cash infusion, led by Nvidia with participation from a who’s who of tech investors, positions Reflection AI to scale up its AI training infrastructure and recruit top talent as it builds cutting-edge AI models accessible to all. With this war chest, Reflection AI plans to accelerate the development of its open-source large language models and challenge global competitors, signaling investor confidence in open AI innovation.

Funding Details:

• Startup: Reflection AI

• Investors: Nvidia (lead), Disruptive, DST Global, 1789 Capital, B Capital, Lightspeed, GIC, Eric Yuan, Eric Schmidt, Citi, Sequoia Capital, CRV (among others)

• Amount Raised: $2 billion

• Total Raised: Approx. $2.13 billion

• Funding Stage: Series B

• Funding Date: Oct 9, 2025

Ecorobotix Secures $105 Million Series D to Advance Precision Agriculture

Ecorobotix, a Swiss agtech startup specializing in AI-guided farm machinery, has raised €90 million ($105 million) in a Series D round to expand its groundbreaking plant-by-plant crop care technology. The Series D funding, combined with 2024’s Series C (€38 million), brings its total funding to $150 million.

Based in Yverdon-les-Bains, Ecorobotix develops smart agricultural equipment—like its ARA sprayer—that uses artificial intelligence and computer vision to identify individual weeds and crops, applying pesticides or fertilizer with pinpoint accuracy only where needed.

This latest funding, led by growth investor Highland Europe with new backing from the European Circular Bioeconomy Fund (ECBF) and McWin Capital Partners, brings Ecorobotix’s total funding to roughly $150 million. With the new capital, the 2014-founded company plans to accelerate development of crop-specific AI algorithms, expand into new crop types and global markets, and scale up manufacturing of its eco-friendly farming solutions that reduce chemical use and boost sustainability.

Funding Details:

• Startup: Ecorobotix

• Investors: Highland Europe (lead), European Circular Bioeconomy Fund (ECBF), McWin Capital Partners (new investors)

• Amount Raised: $105 million

• Total Raised: $150 million (approx.)

• Funding Stage: Series D

• Funding Date: Oct 13, 2025

HavocAI Lands $85 Million in Funding to Scale Autonomous Naval Fleet Technology

HavocAI, a Providence, R.I.-based startup building autonomous maritime systems for defense and commercial uses, has secured $85 million in new funding to accelerate the expansion of its unmanned naval fleet platform. The year-and-a-half-old company has quickly impressed both venture firms and military partners by deploying multiple sizes of autonomous vessels that can swarm and operate with minimal human oversight.

The funding round, co-led by In-Q-Tel (the U.S. intelligence community’s venture arm) and B Capital, includes heavyweight strategic investors such as Lockheed Martin, Hanwha, Taiwania Capital, and others across the U.S. and Indo-Pacific. HavocAI’s total financing now approaches $100 million, a remarkable achievement for a defense-autonomy startup of its age.

The company plans to use the fresh capital to boost production of its robotic boats to meet surging demand from the U.S. Navy (which envisions thousands of deployable autonomous vessels), extend its operations to allied navies abroad, and ensure the operational resilience that defense customers require in cutting-edge dual-use technologies.

Funding Details:

• Startup: HavocAI

• Investors: In-Q-Tel and B Capital (co-leads); Lockheed Martin, Hanwha, Taiwania Capital, Vanderbilt University, Up Partners, Island Green Capital, Zero Infinity Partners; with continued support from Scout Ventures and Outlander Ventures

• Amount Raised: $85 million

• Total Raised: Nearly $100 million

• Funding Stage: Series B (venture round)

• Funding Date: Oct 10, 2025

Excellergy Emerges with $70 Million in Series A Funding for Allergy Therapeutics

Excellergy, a Palo Alto, California biotech startup, has burst onto the scene with a $70 million Series A financing to develop a new class of therapies for severe allergic diseases. The company is pioneering “effector cell response inhibitors” (ECRIs), a novel type of drug designed to intercept allergic reactions at their source by neutralizing IgE immune antibodies before they can trigger inflammation.

This substantial first-round funding was led by Samsara BioCapital, with Red Tree Venture Capital and Decheng Capital also backing the vision. Excellergy, which quietly formed in 2021, is led by CEO Todd Zavodnick (former chief of Dermavant Sciences) and co-founder Dr. Geoffrey Harris. Armed with the new cash, Excellergy plans to advance its preclinical pipeline of ECRI drug candidates into human trials by next year, aiming to redefine the standard of care in allergy treatment with therapies that could provide faster, more complete relief for conditions like food and pollen allergies.

Funding Details:

• Startup: Excellergy

• Investors: Samsara BioCapital (lead), Red Tree Venture Capital, Decheng Capital

• Amount Raised: $70 million

• Total Raised: $70 million+ (including prior seed funding)

• Funding Stage: Series A

• Funding Date: Oct 13, 2025

Resistant AI Bags $25 Million Series B to Fight Financial Fraud

Resistant AI, a Prague-based cybersecurity startup, has raised $25 million in Series B funding to expand its AI-driven fraud detection platform for financial services. Launched in 2019, Resistant AI develops machine learning tools that help banks and fintechs automatically spot forged documents, synthetic identities, money laundering, and other sophisticated fraud tactics. Its solutions – including Resistant Documents for verifying submitted documents and Resistant Transactions for monitoring suspicious behaviors – integrate easily into existing systems to add an extra layer of AI-powered scrutiny.

The new round was led by DTCP Growth (Deutsche Telekom’s investment arm), joined by Notion Capital, Google’s venture arm GV, and credit bureau Experian as strategic backers. With this injection of capital, Resistant AI plans to enter new global markets, enhance its threat intelligence capabilities, and scale up operations, reinforcing its position as a leading defense against financial crime amid growing digital fraud threats.

Funding Details:

• Startup: Resistant AI

• Investors: DTCP Growth (lead), Notion Capital, Google Ventures (GV), Experian

• Amount Raised: $25 million

• Total Raised: ~$55 million

• Funding Stage: Series B

• Funding Date: Oct 13, 2025

ClaimSorted Raises $13.3 Million Seed to Streamline Insurance Claims with AI

ClaimSorted, a London-based insurtech startup, announced a $13.3 million seed funding round to modernize the notoriously slow insurance claims process through artificial intelligence. Co-founded by insurance industry veterans, ClaimSorted was born out of frustration with the delays and errors caused by traditional third-party administrators (TPAs) handling claims.

The startup’s platform combines a seasoned claims management team with a suite of AI agents to automate and speed up key steps in claims handling – aiming to settle claims three times faster than legacy processes while saving insurers significant costs. The fresh funding was led by European venture firm Atomico, with participation from Eurazeo, Y Combinator, Firstminute Capital, Start Ventures, and a network of insurance industry executives.

ClaimSorted plans to use the capital to further develop its AI-driven Claims TPA 2.0 platform, scale its operations, and help insurers deliver a smoother, “five-star” claims experience that boosts customer trust and retention.

Funding Details:

• Startup: ClaimSorted

• Investors: Atomico (lead), Eurazeo, Y Combinator, Firstminute Capital, Start Ventures, and various insurance industry angels

• Amount Raised: $13.3 million

• Total Raised: $13.3 million (seed round)

• Funding Stage: Seed

• Funding Date: Oct 13, 2025

GoodScore Secures $13 Million in Series A Funding to Boost AI-Powered Credit Health Platform

GoodScore, a Bengaluru-based fintech startup, has raised $13 million in a Series A round to scale its AI-driven platform that helps consumers track and improve their credit health. Led by Peak XV Partners (formerly Sequoia India), with participation from Stellaris Venture Partners and Saison Capital, the funding underscores growing investor interest in tools for responsible lending in India’s booming digital credit market.

Founded in 2023 by Sanchit Bansal, GoodScore aggregates users’ credit bureau data and financial behaviors into a single app, offering personalized insights to improve credit scores, manage loan repayments, and avoid over-borrowing. Millions of users – especially in India’s smaller cities – have already adopted the app to monitor their credit and connect with lending offers. With the new capital, GoodScore plans to enhance its AI advisory features, expand its product and engineering teams, and grow its credit marketplace that links borrowers with banks and fintech lenders, all in an effort to foster healthier borrowing habits across India’s 250+ million borrower base.

Funding Details:

• Startup: GoodScore

• Investors: Peak XV Partners (lead), Stellaris Venture Partners, Saison Capital (among others)

• Amount Raised: $13 million

• Total Raised: ~$18 million

• Funding Stage: Series A

• Funding Date: Oct 13, 2025

Salt AI Raises $10 Million in Pre-Series A Funding to Accelerate AI in Life Sciences

Salt AI, a Los Angeles-based life sciences and healthtech startup, has secured $10 million in a pre-Series A funding round to expand its contextual AI platform for pharmaceutical and biotech research. Salt AI’s software enables researchers and healthcare companies to build and deploy custom AI models for tasks ranging from drug discovery and clinical trial analytics to revenue cycle management. The round was led by Morpheus Ventures, with participation from Struck Capital, Marbruck Investments, and cloud infrastructure partner CoreWeave.

Salt AI was co-founded by CEO Aber Whitcomb (MySpace co-founder turned healthtech entrepreneur) and has already made an impact at institutions like the Ellison Institute, where its platform has been used since 2024 to design and analyze thousands of potential drug compounds faster than traditional methods. With the new funding, Salt AI aims to grow its customer base among leading biopharma companies and further develop its “AI workflow” toolkit, empowering life science teams to integrate advanced AI into everyday research and operational workflows.

Funding Details:

• Startup: Salt AI

• Investors: Morpheus Ventures (lead), Struck Capital, Marbruck Investments, CoreWeave

• Amount Raised: $10 million

• Total Raised: $13 million (including prior seed round)

• Funding Stage: Pre-Series A (seed extension)

• Funding Date: Oct 13, 2025

Tech Funding Summary Table